Genetics Generation Advancement Corp. (TPEX:4160)

Market Cap	1.20B -36.3%
Revenue (ttm)	603.11M -8.9%
Net Income	21.37M -60.9%
EPS	0.80 -60.8%
Shares Out	26.69M
PE Ratio	56.06
Forward PE	n/a
Dividend	1.85 (4.17%)
Ex-Dividend Date	Oct 3, 2025

Volume	49,505
Average Volume	65,106
Open	44.35
Previous Close	44.30
Day's Range	44.35 - 45.20
52-Week Range	43.05 - 68.40
Beta	0.41
RSI	35.45
Earnings Date	Mar 26, 2026

About TPEX:4160

Genetics Generation Advancement Corp. provides genetic testing, molecular and science diagnostics, biotechnology, precision health, and digital innovation services in Taiwan. The company offers testing services, including pre-implantation, prenatal, newborn medical examination, health management, reproductive medicine testing, obstetrics and gynecology testing, and neonatology and pediatrics testing, as well as gastroenterology, hepatology, oncology, and medical research services. It also provides bioinformatic, materials sciences, research and...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 2008
• Employees: 104
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 4160

Financial Performance

In 2025, TPEX:4160's revenue was 603.11 million, a decrease of -8.88% compared to the previous year's 661.86 million. Earnings were 21.37 million, a decrease of -60.93%.